To: bob smith who wrote (17515 ) 3/17/1998 12:13:00 AM From: Bagle Read Replies (1) | Respond to of 32384
I was at the meeting--very interesting. Crossen is compelling and he certainly had some interesting data and interesting picks based on what seemed to be very specific research. A bunch of people stuck around after and cornered Crossen and literally pummeled him with every biotech stock under the sun. Ligand came up and he seemed to give a sly smile and he commented, "they certainly are interesting." Quite a fascinating/meaningless piece of information if I do say so myself. His stories, however, were golden. You couldn't see the slides from the seats, but his data paints an interesting picture of investing in biotechs. I'd recommend the audio tape because he gave the specifics on what to buy, why to buy it, and when--exactly--to make the investment for a positive return and without having your $$ sit around too far in advance of an event. I did, however, disagree with a few of his picks on which I think I am knowledgeable. Other picks, from his description, seem to be no-brainers. He definitely seemed to be indicating that the BIG EVENT would be guessing who Amgen would buy--but he gave no indication or even hint at which company. Mr. Niman, any data on the Amgen hit rate at your Ligand site? FYI, price can have a huge impact on sales of a new drug (BTW, it can also have no impact). Crossen threw out quite a few prices in the after-seminar cornering which certainly shed light on a number of stocks I follow. I find that information hard to come by before a product's launch--very informative and very worth the $20 and a few hours of my time. I'd recommend these forums--coming up in Seattle, Colorado, San Diego, San Francisco, and I think LA.